重症老年AKI患者肾脏替代治疗的选择与实施
这项在加拿大16家医院开展的前瞻性队列研究纳入499例≥65岁重症AKI患者,记录肾脏替代治疗(KRT)的触发因素、未实施原因及90天死亡率。结果显示72%患者被评估为可考虑KRT,46%实际接受KRT,接受与未接受者90天死亡率相似(50% vs 51%;调整HR 0.78,95%CI 0.58-1.06),但提供KRT的意愿和未启动原因因患者因素和临床医生判断而存在异质性。
要点
- 重症老年AKI患者中约72%被评估为KRT候选者,46%实际接受KRT。
- 接受与未接受KRT者90天死亡率无显著差异(50% vs 51%;调整HR 0.78,95%CI 0.58-1.06)。
- 未实施KRT主因是预期肾功能恢复(67%)和治疗与患者意愿不符(24%)。
核心结论
- 多数重症老年严重AKI患者被认为适合KRT,约半数实际接受治疗。
- 提供KRT的意愿及未启动原因因患者因素和临床医生对获益的判断而异。
研究设计与样本
- 入选标准为年龄≥65岁、重症、严重AKI;排除因毒素需紧急KRT和ESKD者。
- 共499例患者,平均年龄75(7)岁,Charlson合并症评分3.0(2.3),临床衰弱量表中位数4(3-5)。
主要发现
- 64%(n=319)接受机械通气,63%(n=314)使用血管活性药物。
- 临床医生愿意为361例(72%)提供KRT,229例(46%)实际接受KRT。
- KRT主要触发因素为少尿/无尿、容量过负荷和酸血症。
- 未接受KRT主因为预期恢复(67%;n=181)和治疗与患者偏好不一致(24%;n=66)。
- 接受与未接受KRT者90天死亡率相似(50% vs 51%;调整HR 0.78,95%CI 0.58-1.06)。
临床怎么用
- 对重症老年严重AKI患者,应个体化评估KRT获益与患者偏好。
- 预期肾功能恢复和治疗是否符合患者意愿是决定是否启动KRT的重要考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Older patients in the intensive care unit are at greater risk of AKI; however, use of kidney replacement therapy in this population is poorly characterized. We describe the triggers and outcomes associated with kidney replacement therapy in older patients with AKI in the intensive care unit. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study was a prospective cohort study in 16 Canadian hospitals from September 2013 to November 2015. Patients were ≥65 years old, were critically ill, and had severe AKI; exclusion criteria were urgent kidney replacement therapy for a toxin and ESKD. We recorded triggers for kidney replacement therapy (primary exposure), reasons for not receiving kidney replacement therapy, 90-day mortality (primary outcome), and kidney recovery. RESULTS: Of 499 patients, mean (SD) age was 75 (7) years old, Charlson comorbidity score was 3.0 (2.3), and median (interquartile range) Clinical Frailty Scale score was 4 (3-5). Most were receiving mechanical ventilation (64%; n=319) and vasoactive support (63%; n=314). Clinicians were willing to offer kidney replacement therapy to 361 (72%) patients, and 229 (46%) received kidney replacement therapy. Main triggers for kidney replacement therapy were oligoanuria, fluid overload, and acidemia, whereas main reasons for not receiving therapy were anticipated recovery (67%; n=181) and therapy not consistent with patient preferences for care (24%; n=66). Ninety-day mortality was similar in patients who did and did not receive kidney replacement therapy (50% versus 51%; adjusted hazard ratio, 0.78; 95% confidence interval, 0.58 to 1.06); however, decisions to offer kidney replacement therapy varied significantly by patient mix, acuity, and perceived benefit. There were no differences in health-related quality of life or rehospitalization among survivors. CONCLUSIONS: Most older, critically ill patients with severe AKI were perceived as candidates for kidney replacement therapy, and approximately one half received therapy. Both willingness to offer kidney replacement therapy and reasons for not starting showed heterogeneity due to a range in patient-specific factors and clinician perceptions of benefit.
引用
- Bagshaw SM, Adhikari NKJ, Burns KEA, et al. Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI. Clin J Am Soc Nephrol. 2019. PMID: 30898872. doi:10.2215/CJN.05530518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。